Effect of Focal and Grid Pattern PASCAL Photocoagulation Treatment in Diabetic Macular Edema.
10.3341/jkos.2011.52.2.197
- Author:
Jae Kwan PARK
1
;
Woo Jin JEUNG
Author Information
1. Department of Ophthalmology, Dong-A University College of Medicine, Busan, Korea. wjeye@dau.ac.kr
- Publication Type:Original Article
- Keywords:
Diabetic macular edema;
Pascal photocoagulation
- MeSH:
Antibodies, Monoclonal, Humanized;
Argon;
Eye;
Humans;
Light Coagulation;
Macular Edema;
Retrospective Studies;
Visual Acuity;
Bevacizumab
- From:Journal of the Korean Ophthalmological Society
2011;52(2):197-202
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To investigate the effect of focal and grid pattern PASCAL photocoagulation treatment in diabetic macular edema patients. METHODS: A total of 72 patients (75 eyes) who were diagnosed as diabetic macular edema were retrospectively analyzed. The patients were divided into 3 groups as follows: group 1 (31 patients, 31 eyes) received an intravitreal bevacizumab injection, group 2 (17 patients, 20 eyes) underwent focal and grid pattern PASCAL photocoagulation treatment, and group 3 (24 patients, 24 eyes) underwent focal and grid pattern argon photocoagulation treatment. Macular thickness and visual acuity (logMAR) of 75 eyes were compared among groups before and after treatments. RESULTS: Visual acuity improved in 13 eyes (65.0%) in group 1, 16 eyes (51.6%) in group 2, and in 10 eyes (41.6%) in group 3; however, there was no statistical significance. Macular thickness reduction occurred in 24 eyes (77.4%) in group 1 and 13 eyes (65.0%) in group 2 which were statistically significant decreases at only 1 month after treatment (p < 0.05). CONCLUSIONS: Focal and grid pattern PASCAL photocoagulation is a good therapeutic option for diabetic macular edema. Focal and grid pattern PASCAL photocoagulation is as effective as intravitreal bevacizumab injection or focal and grid pattern argon photocoagulation treatment.
